nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2B6—malignant glioma	0.35	0.54	CbGaD
Sertraline—SLC6A3—malignant glioma	0.299	0.46	CbGaD
Sertraline—CYP1A2—Carmustine—malignant glioma	0.0774	0.569	CbGbCtD
Sertraline—CYP3A4—Temozolomide—malignant glioma	0.0585	0.43	CbGbCtD
Sertraline—Dysphasia—Temozolomide—malignant glioma	0.00346	0.0299	CcSEcCtD
Sertraline—SLC6A3—telencephalic ventricle—malignant glioma	0.00307	0.109	CbGeAlD
Sertraline—Hyperacusis—Temozolomide—malignant glioma	0.00203	0.0175	CcSEcCtD
Sertraline—Paranoid reaction—Carmustine—malignant glioma	0.00184	0.0159	CcSEcCtD
Sertraline—Faecal incontinence—Carmustine—malignant glioma	0.00155	0.0134	CcSEcCtD
Sertraline—Faecal incontinence—Temozolomide—malignant glioma	0.0015	0.0129	CcSEcCtD
Sertraline—Cerebration impaired—Temozolomide—malignant glioma	0.00128	0.0111	CcSEcCtD
Sertraline—Haemorrhoids—Temozolomide—malignant glioma	0.00128	0.0111	CcSEcCtD
Sertraline—Aphasia—Carmustine—malignant glioma	0.0012	0.0104	CcSEcCtD
Sertraline—Aphasia—Temozolomide—malignant glioma	0.00116	0.0101	CcSEcCtD
Sertraline—Hypokinesia—Carmustine—malignant glioma	0.00116	0.01	CcSEcCtD
Sertraline—Paranoia—Carmustine—malignant glioma	0.00115	0.0099	CcSEcCtD
Sertraline—Digestion impaired—Temozolomide—malignant glioma	0.00113	0.00976	CcSEcCtD
Sertraline—Maprotiline—SLC6A3—malignant glioma	0.00111	1	CrCbGaD
Sertraline—Apathy—Temozolomide—malignant glioma	0.00106	0.00913	CcSEcCtD
Sertraline—Flat affect—Temozolomide—malignant glioma	0.00105	0.00905	CcSEcCtD
Sertraline—Stupor—Carmustine—malignant glioma	0.00105	0.00904	CcSEcCtD
Sertraline—Scotoma—Carmustine—malignant glioma	0.00103	0.00889	CcSEcCtD
Sertraline—Menorrhagia—Temozolomide—malignant glioma	0.00102	0.00881	CcSEcCtD
Sertraline—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00102	0.00881	CcSEcCtD
Sertraline—Extrapyramidal disorder—Temozolomide—malignant glioma	0.001	0.00866	CcSEcCtD
Sertraline—Necrosis—Carmustine—malignant glioma	0.000996	0.0086	CcSEcCtD
Sertraline—Scotoma—Temozolomide—malignant glioma	0.000994	0.00859	CcSEcCtD
Sertraline—Otitis media—Temozolomide—malignant glioma	0.00097	0.00838	CcSEcCtD
Sertraline—Hyperaesthesia—Temozolomide—malignant glioma	0.000962	0.00831	CcSEcCtD
Sertraline—Rigors—Temozolomide—malignant glioma	0.000925	0.00799	CcSEcCtD
Sertraline—Endocrine disorder—Temozolomide—malignant glioma	0.000911	0.00787	CcSEcCtD
Sertraline—Speech disorder—Carmustine—malignant glioma	0.000908	0.00785	CcSEcCtD
Sertraline—Speech disorder—Temozolomide—malignant glioma	0.000878	0.00758	CcSEcCtD
Sertraline—Disturbance in attention—Temozolomide—malignant glioma	0.000872	0.00753	CcSEcCtD
Sertraline—Breast pain—Temozolomide—malignant glioma	0.000865	0.00747	CcSEcCtD
Sertraline—Amenorrhoea—Temozolomide—malignant glioma	0.000859	0.00742	CcSEcCtD
Sertraline—Thinking abnormal—Carmustine—malignant glioma	0.000854	0.00737	CcSEcCtD
Sertraline—SLC6A3—brainstem—malignant glioma	0.000831	0.0295	CbGeAlD
Sertraline—Gait disturbance—Carmustine—malignant glioma	0.000801	0.00691	CcSEcCtD
Sertraline—Coordination abnormal—Carmustine—malignant glioma	0.000796	0.00687	CcSEcCtD
Sertraline—MAOB—embryo—malignant glioma	0.00079	0.028	CbGeAlD
Sertraline—Gait disturbance—Temozolomide—malignant glioma	0.000774	0.00668	CcSEcCtD
Sertraline—Coordination abnormal—Temozolomide—malignant glioma	0.000769	0.00664	CcSEcCtD
Sertraline—Respiratory failure—Temozolomide—malignant glioma	0.000769	0.00664	CcSEcCtD
Sertraline—SLC6A4—brainstem—malignant glioma	0.000761	0.027	CbGeAlD
Sertraline—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000755	0.00652	CcSEcCtD
Sertraline—Urinary incontinence—Carmustine—malignant glioma	0.000755	0.00652	CcSEcCtD
Sertraline—Depressed level of consciousness—Carmustine—malignant glioma	0.000755	0.00652	CcSEcCtD
Sertraline—SLC6A3—telencephalon—malignant glioma	0.000737	0.0262	CbGeAlD
Sertraline—Depressed level of consciousness—Temozolomide—malignant glioma	0.000729	0.0063	CcSEcCtD
Sertraline—Urinary incontinence—Temozolomide—malignant glioma	0.000729	0.0063	CcSEcCtD
Sertraline—MAOB—brainstem—malignant glioma	0.000724	0.0257	CbGeAlD
Sertraline—Coma—Carmustine—malignant glioma	0.000714	0.00617	CcSEcCtD
Sertraline—Aplastic anaemia—Temozolomide—malignant glioma	0.000709	0.00612	CcSEcCtD
Sertraline—Neoplasm—Carmustine—malignant glioma	0.000706	0.0061	CcSEcCtD
Sertraline—Gynaecomastia—Carmustine—malignant glioma	0.000699	0.00604	CcSEcCtD
Sertraline—Neoplasm—Temozolomide—malignant glioma	0.000683	0.0059	CcSEcCtD
Sertraline—Abnormal vision—Carmustine—malignant glioma	0.000681	0.00589	CcSEcCtD
Sertraline—Mental disability—Carmustine—malignant glioma	0.000678	0.00586	CcSEcCtD
Sertraline—SLC6A4—telencephalon—malignant glioma	0.000676	0.024	CbGeAlD
Sertraline—MAOA—embryo—malignant glioma	0.000674	0.0239	CbGeAlD
Sertraline—SIGMAR1—telencephalon—malignant glioma	0.000671	0.0238	CbGeAlD
Sertraline—SLC6A2—brainstem—malignant glioma	0.00067	0.0238	CbGeAlD
Sertraline—Abnormal vision—Temozolomide—malignant glioma	0.000659	0.00569	CcSEcCtD
Sertraline—Mental disability—Temozolomide—malignant glioma	0.000655	0.00566	CcSEcCtD
Sertraline—Diabetes mellitus—Carmustine—malignant glioma	0.000652	0.00563	CcSEcCtD
Sertraline—MAOB—telencephalon—malignant glioma	0.000642	0.0228	CbGeAlD
Sertraline—Ear pain—Temozolomide—malignant glioma	0.000642	0.00555	CcSEcCtD
Sertraline—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00063	0.00544	CcSEcCtD
Sertraline—Eye pain—Carmustine—malignant glioma	0.000628	0.00543	CcSEcCtD
Sertraline—Gastroenteritis—Temozolomide—malignant glioma	0.000618	0.00534	CcSEcCtD
Sertraline—MAOA—brainstem—malignant glioma	0.000618	0.0219	CbGeAlD
Sertraline—Vascular purpura—Temozolomide—malignant glioma	0.000613	0.00529	CcSEcCtD
Sertraline—Hepatic failure—Temozolomide—malignant glioma	0.00061	0.00527	CcSEcCtD
Sertraline—Eye pain—Temozolomide—malignant glioma	0.000607	0.00524	CcSEcCtD
Sertraline—Amnesia—Carmustine—malignant glioma	0.000604	0.00521	CcSEcCtD
Sertraline—MAOA—retina—malignant glioma	0.000596	0.0211	CbGeAlD
Sertraline—SLC6A2—telencephalon—malignant glioma	0.000595	0.0211	CbGeAlD
Sertraline—Hot flush—Temozolomide—malignant glioma	0.000586	0.00506	CcSEcCtD
Sertraline—Amnesia—Temozolomide—malignant glioma	0.000583	0.00504	CcSEcCtD
Sertraline—Menopausal symptoms—Temozolomide—malignant glioma	0.000581	0.00502	CcSEcCtD
Sertraline—Thirst—Temozolomide—malignant glioma	0.000576	0.00497	CcSEcCtD
Sertraline—Hyponatraemia—Carmustine—malignant glioma	0.000569	0.00492	CcSEcCtD
Sertraline—Purpura—Temozolomide—malignant glioma	0.000569	0.00491	CcSEcCtD
Sertraline—Diplopia—Carmustine—malignant glioma	0.000567	0.0049	CcSEcCtD
Sertraline—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000567	0.0049	CcSEcCtD
Sertraline—MAOA—telencephalon—malignant glioma	0.000548	0.0195	CbGeAlD
Sertraline—Diplopia—Temozolomide—malignant glioma	0.000548	0.00473	CcSEcCtD
Sertraline—Face oedema—Carmustine—malignant glioma	0.000548	0.00473	CcSEcCtD
Sertraline—Affect lability—Temozolomide—malignant glioma	0.00054	0.00466	CcSEcCtD
Sertraline—Ataxia—Carmustine—malignant glioma	0.000533	0.00461	CcSEcCtD
Sertraline—SLC6A3—midbrain—malignant glioma	0.00053	0.0188	CbGeAlD
Sertraline—Face oedema—Temozolomide—malignant glioma	0.000529	0.00457	CcSEcCtD
Sertraline—SIGMAR1—medulla oblongata—malignant glioma	0.000527	0.0187	CbGeAlD
Sertraline—Mood swings—Temozolomide—malignant glioma	0.000519	0.00448	CcSEcCtD
Sertraline—SLC6A3—spinal cord—malignant glioma	0.000517	0.0183	CbGeAlD
Sertraline—Ataxia—Temozolomide—malignant glioma	0.000515	0.00445	CcSEcCtD
Sertraline—Dehydration—Temozolomide—malignant glioma	0.00051	0.0044	CcSEcCtD
Sertraline—MAOB—medulla oblongata—malignant glioma	0.000505	0.0179	CbGeAlD
Sertraline—Dry skin—Temozolomide—malignant glioma	0.000502	0.00434	CcSEcCtD
Sertraline—Muscular weakness—Carmustine—malignant glioma	0.0005	0.00432	CcSEcCtD
Sertraline—Breast disorder—Temozolomide—malignant glioma	0.000495	0.00428	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000494	0.00426	CcSEcCtD
Sertraline—Dysphagia—Carmustine—malignant glioma	0.00049	0.00423	CcSEcCtD
Sertraline—SLC6A4—midbrain—malignant glioma	0.000485	0.0172	CbGeAlD
Sertraline—Muscular weakness—Temozolomide—malignant glioma	0.000483	0.00418	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000483	0.00418	CcSEcCtD
Sertraline—ABCB1—blood vessel—malignant glioma	0.000483	0.0171	CbGeAlD
Sertraline—SIGMAR1—midbrain—malignant glioma	0.000482	0.0171	CbGeAlD
Sertraline—Abdominal distension—Temozolomide—malignant glioma	0.000477	0.00412	CcSEcCtD
Sertraline—Dysphagia—Temozolomide—malignant glioma	0.000474	0.00409	CcSEcCtD
Sertraline—SLC6A4—spinal cord—malignant glioma	0.000473	0.0168	CbGeAlD
Sertraline—SIGMAR1—spinal cord—malignant glioma	0.00047	0.0167	CbGeAlD
Sertraline—SLC6A2—medulla oblongata—malignant glioma	0.000467	0.0166	CbGeAlD
Sertraline—Pancytopenia—Carmustine—malignant glioma	0.000466	0.00402	CcSEcCtD
Sertraline—Sweating increased—Temozolomide—malignant glioma	0.000461	0.00399	CcSEcCtD
Sertraline—MAOB—midbrain—malignant glioma	0.000461	0.0164	CbGeAlD
Sertraline—Bronchitis—Temozolomide—malignant glioma	0.000456	0.00393	CcSEcCtD
Sertraline—MAOB—spinal cord—malignant glioma	0.00045	0.016	CbGeAlD
Sertraline—Pancytopenia—Temozolomide—malignant glioma	0.00045	0.00389	CcSEcCtD
Sertraline—Dysuria—Temozolomide—malignant glioma	0.000443	0.00383	CcSEcCtD
Sertraline—Hyperglycaemia—Carmustine—malignant glioma	0.000442	0.00382	CcSEcCtD
Sertraline—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00044	0.0038	CcSEcCtD
Sertraline—Pollakiuria—Temozolomide—malignant glioma	0.000438	0.00378	CcSEcCtD
Sertraline—Erectile dysfunction—Temozolomide—malignant glioma	0.000436	0.00377	CcSEcCtD
Sertraline—Depression—Carmustine—malignant glioma	0.000436	0.00376	CcSEcCtD
Sertraline—Photosensitivity reaction—Temozolomide—malignant glioma	0.000432	0.00373	CcSEcCtD
Sertraline—Weight increased—Temozolomide—malignant glioma	0.000431	0.00372	CcSEcCtD
Sertraline—MAOA—medulla oblongata—malignant glioma	0.000431	0.0153	CbGeAlD
Sertraline—Weight decreased—Temozolomide—malignant glioma	0.000429	0.0037	CcSEcCtD
Sertraline—Neuropathy peripheral—Carmustine—malignant glioma	0.000428	0.0037	CcSEcCtD
Sertraline—Hyperglycaemia—Temozolomide—malignant glioma	0.000427	0.00369	CcSEcCtD
Sertraline—Stomatitis—Carmustine—malignant glioma	0.000426	0.00368	CcSEcCtD
Sertraline—Depression—Temozolomide—malignant glioma	0.000421	0.00364	CcSEcCtD
Sertraline—SLC6A3—central nervous system—malignant glioma	0.000419	0.0149	CbGeAlD
Sertraline—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000419	0.00362	CcSEcCtD
Sertraline—Neuropathy peripheral—Temozolomide—malignant glioma	0.000414	0.00358	CcSEcCtD
Sertraline—Stomatitis—Temozolomide—malignant glioma	0.000412	0.00356	CcSEcCtD
Sertraline—SLC6A3—cerebellum—malignant glioma	0.00041	0.0145	CbGeAlD
Sertraline—Hepatobiliary disease—Temozolomide—malignant glioma	0.000399	0.00345	CcSEcCtD
Sertraline—Sinusitis—Temozolomide—malignant glioma	0.000396	0.00342	CcSEcCtD
Sertraline—Haemoglobin—Carmustine—malignant glioma	0.000394	0.00341	CcSEcCtD
Sertraline—MAOA—midbrain—malignant glioma	0.000394	0.014	CbGeAlD
Sertraline—Haemorrhage—Carmustine—malignant glioma	0.000392	0.00339	CcSEcCtD
Sertraline—Hallucination—Carmustine—malignant glioma	0.00039	0.00337	CcSEcCtD
Sertraline—Hypoaesthesia—Carmustine—malignant glioma	0.00039	0.00337	CcSEcCtD
Sertraline—Oedema peripheral—Carmustine—malignant glioma	0.000387	0.00334	CcSEcCtD
Sertraline—Connective tissue disorder—Carmustine—malignant glioma	0.000386	0.00333	CcSEcCtD
Sertraline—SLC6A4—central nervous system—malignant glioma	0.000384	0.0136	CbGeAlD
Sertraline—MAOA—spinal cord—malignant glioma	0.000384	0.0136	CbGeAlD
Sertraline—Haemoglobin—Temozolomide—malignant glioma	0.000381	0.00329	CcSEcCtD
Sertraline—Hepatitis—Temozolomide—malignant glioma	0.000379	0.00327	CcSEcCtD
Sertraline—Haemorrhage—Temozolomide—malignant glioma	0.000379	0.00327	CcSEcCtD
Sertraline—Visual impairment—Carmustine—malignant glioma	0.000378	0.00327	CcSEcCtD
Sertraline—Hallucination—Temozolomide—malignant glioma	0.000377	0.00326	CcSEcCtD
Sertraline—Hypoaesthesia—Temozolomide—malignant glioma	0.000377	0.00326	CcSEcCtD
Sertraline—Pharyngitis—Temozolomide—malignant glioma	0.000376	0.00325	CcSEcCtD
Sertraline—Urinary tract disorder—Temozolomide—malignant glioma	0.000374	0.00323	CcSEcCtD
Sertraline—Oedema peripheral—Temozolomide—malignant glioma	0.000374	0.00323	CcSEcCtD
Sertraline—SIGMAR1—cerebellum—malignant glioma	0.000373	0.0132	CbGeAlD
Sertraline—Connective tissue disorder—Temozolomide—malignant glioma	0.000373	0.00322	CcSEcCtD
Sertraline—Urethral disorder—Temozolomide—malignant glioma	0.000372	0.00321	CcSEcCtD
Sertraline—CYP2D6—brainstem—malignant glioma	0.000367	0.013	CbGeAlD
Sertraline—Eye disorder—Carmustine—malignant glioma	0.000367	0.00317	CcSEcCtD
Sertraline—Visual impairment—Temozolomide—malignant glioma	0.000365	0.00316	CcSEcCtD
Sertraline—MAOB—central nervous system—malignant glioma	0.000365	0.013	CbGeAlD
Sertraline—Flushing—Carmustine—malignant glioma	0.000364	0.00315	CcSEcCtD
Sertraline—Erythema multiforme—Temozolomide—malignant glioma	0.000359	0.0031	CcSEcCtD
Sertraline—MAOB—cerebellum—malignant glioma	0.000357	0.0127	CbGeAlD
Sertraline—Eye disorder—Temozolomide—malignant glioma	0.000354	0.00306	CcSEcCtD
Sertraline—Tinnitus—Temozolomide—malignant glioma	0.000354	0.00305	CcSEcCtD
Sertraline—Cardiac disorder—Temozolomide—malignant glioma	0.000352	0.00304	CcSEcCtD
Sertraline—Flushing—Temozolomide—malignant glioma	0.000352	0.00304	CcSEcCtD
Sertraline—Arrhythmia—Carmustine—malignant glioma	0.000351	0.00303	CcSEcCtD
Sertraline—Alopecia—Carmustine—malignant glioma	0.000347	0.00299	CcSEcCtD
Sertraline—Angiopathy—Temozolomide—malignant glioma	0.000344	0.00297	CcSEcCtD
Sertraline—Mental disorder—Carmustine—malignant glioma	0.000344	0.00297	CcSEcCtD
Sertraline—Immune system disorder—Temozolomide—malignant glioma	0.000343	0.00296	CcSEcCtD
Sertraline—Mediastinal disorder—Temozolomide—malignant glioma	0.000342	0.00295	CcSEcCtD
Sertraline—Erythema—Carmustine—malignant glioma	0.000342	0.00295	CcSEcCtD
Sertraline—Malnutrition—Carmustine—malignant glioma	0.000342	0.00295	CcSEcCtD
Sertraline—Chills—Temozolomide—malignant glioma	0.00034	0.00294	CcSEcCtD
Sertraline—SLC6A2—central nervous system—malignant glioma	0.000338	0.012	CbGeAlD
Sertraline—Alopecia—Temozolomide—malignant glioma	0.000335	0.00289	CcSEcCtD
Sertraline—SLC6A3—brain—malignant glioma	0.000333	0.0118	CbGeAlD
Sertraline—Mental disorder—Temozolomide—malignant glioma	0.000332	0.00287	CcSEcCtD
Sertraline—Back pain—Carmustine—malignant glioma	0.00033	0.00285	CcSEcCtD
Sertraline—Erythema—Temozolomide—malignant glioma	0.00033	0.00285	CcSEcCtD
Sertraline—Malnutrition—Temozolomide—malignant glioma	0.00033	0.00285	CcSEcCtD
Sertraline—CYP2D6—telencephalon—malignant glioma	0.000326	0.0116	CbGeAlD
Sertraline—Dysgeusia—Temozolomide—malignant glioma	0.000323	0.00279	CcSEcCtD
Sertraline—Tremor—Carmustine—malignant glioma	0.00032	0.00276	CcSEcCtD
Sertraline—Back pain—Temozolomide—malignant glioma	0.000319	0.00276	CcSEcCtD
Sertraline—Anaemia—Carmustine—malignant glioma	0.000316	0.00273	CcSEcCtD
Sertraline—Agitation—Carmustine—malignant glioma	0.000314	0.00271	CcSEcCtD
Sertraline—MAOA—central nervous system—malignant glioma	0.000312	0.0111	CbGeAlD
Sertraline—Tremor—Temozolomide—malignant glioma	0.000309	0.00267	CcSEcCtD
Sertraline—Ill-defined disorder—Temozolomide—malignant glioma	0.000306	0.00265	CcSEcCtD
Sertraline—Leukopenia—Carmustine—malignant glioma	0.000306	0.00264	CcSEcCtD
Sertraline—Anaemia—Temozolomide—malignant glioma	0.000305	0.00263	CcSEcCtD
Sertraline—SLC6A4—brain—malignant glioma	0.000305	0.0108	CbGeAlD
Sertraline—MAOA—cerebellum—malignant glioma	0.000305	0.0108	CbGeAlD
Sertraline—Agitation—Temozolomide—malignant glioma	0.000303	0.00262	CcSEcCtD
Sertraline—SIGMAR1—brain—malignant glioma	0.000303	0.0107	CbGeAlD
Sertraline—Angioedema—Temozolomide—malignant glioma	0.000302	0.0026	CcSEcCtD
Sertraline—Malaise—Temozolomide—malignant glioma	0.000298	0.00257	CcSEcCtD
Sertraline—Vertigo—Temozolomide—malignant glioma	0.000297	0.00256	CcSEcCtD
Sertraline—Convulsion—Carmustine—malignant glioma	0.000296	0.00256	CcSEcCtD
Sertraline—Leukopenia—Temozolomide—malignant glioma	0.000295	0.00255	CcSEcCtD
Sertraline—Hypertension—Carmustine—malignant glioma	0.000295	0.00255	CcSEcCtD
Sertraline—Palpitations—Temozolomide—malignant glioma	0.000292	0.00252	CcSEcCtD
Sertraline—Chest pain—Carmustine—malignant glioma	0.000291	0.00251	CcSEcCtD
Sertraline—Myalgia—Carmustine—malignant glioma	0.000291	0.00251	CcSEcCtD
Sertraline—MAOB—brain—malignant glioma	0.00029	0.0103	CbGeAlD
Sertraline—Anxiety—Carmustine—malignant glioma	0.00029	0.0025	CcSEcCtD
Sertraline—ABCB1—embryo—malignant glioma	0.000288	0.0102	CbGeAlD
Sertraline—Cough—Temozolomide—malignant glioma	0.000288	0.00249	CcSEcCtD
Sertraline—Convulsion—Temozolomide—malignant glioma	0.000286	0.00247	CcSEcCtD
Sertraline—Hypertension—Temozolomide—malignant glioma	0.000285	0.00246	CcSEcCtD
Sertraline—Confusional state—Carmustine—malignant glioma	0.000281	0.00243	CcSEcCtD
Sertraline—Arthralgia—Temozolomide—malignant glioma	0.000281	0.00243	CcSEcCtD
Sertraline—Myalgia—Temozolomide—malignant glioma	0.000281	0.00243	CcSEcCtD
Sertraline—Anxiety—Temozolomide—malignant glioma	0.00028	0.00242	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000279	0.00241	CcSEcCtD
Sertraline—Oedema—Carmustine—malignant glioma	0.000279	0.00241	CcSEcCtD
Sertraline—Discomfort—Temozolomide—malignant glioma	0.000278	0.0024	CcSEcCtD
Sertraline—Dry mouth—Temozolomide—malignant glioma	0.000275	0.00237	CcSEcCtD
Sertraline—Thrombocytopenia—Carmustine—malignant glioma	0.000273	0.00236	CcSEcCtD
Sertraline—Tachycardia—Carmustine—malignant glioma	0.000272	0.00235	CcSEcCtD
Sertraline—Confusional state—Temozolomide—malignant glioma	0.000272	0.00235	CcSEcCtD
Sertraline—Oedema—Temozolomide—malignant glioma	0.000269	0.00233	CcSEcCtD
Sertraline—Anaphylactic shock—Temozolomide—malignant glioma	0.000269	0.00233	CcSEcCtD
Sertraline—SLC6A2—brain—malignant glioma	0.000268	0.00953	CbGeAlD
Sertraline—Anorexia—Carmustine—malignant glioma	0.000266	0.00229	CcSEcCtD
Sertraline—Nervous system disorder—Temozolomide—malignant glioma	0.000264	0.00228	CcSEcCtD
Sertraline—Thrombocytopenia—Temozolomide—malignant glioma	0.000264	0.00228	CcSEcCtD
Sertraline—Skin disorder—Temozolomide—malignant glioma	0.000262	0.00226	CcSEcCtD
Sertraline—Hypotension—Carmustine—malignant glioma	0.000261	0.00225	CcSEcCtD
Sertraline—Hyperhidrosis—Temozolomide—malignant glioma	0.00026	0.00225	CcSEcCtD
Sertraline—Anorexia—Temozolomide—malignant glioma	0.000257	0.00222	CcSEcCtD
Sertraline—ABCB1—retina—malignant glioma	0.000255	0.00904	CbGeAlD
Sertraline—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000254	0.00219	CcSEcCtD
Sertraline—Insomnia—Carmustine—malignant glioma	0.000252	0.00218	CcSEcCtD
Sertraline—Paraesthesia—Carmustine—malignant glioma	0.00025	0.00216	CcSEcCtD
Sertraline—CYP2B6—central nervous system—malignant glioma	0.000249	0.00884	CbGeAlD
Sertraline—Dyspnoea—Carmustine—malignant glioma	0.000249	0.00215	CcSEcCtD
Sertraline—Somnolence—Carmustine—malignant glioma	0.000248	0.00214	CcSEcCtD
Sertraline—MAOA—brain—malignant glioma	0.000247	0.00878	CbGeAlD
Sertraline—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000245	0.00212	CcSEcCtD
Sertraline—Insomnia—Temozolomide—malignant glioma	0.000244	0.0021	CcSEcCtD
Sertraline—Decreased appetite—Carmustine—malignant glioma	0.000242	0.00209	CcSEcCtD
Sertraline—Paraesthesia—Temozolomide—malignant glioma	0.000242	0.00209	CcSEcCtD
Sertraline—Gastrointestinal disorder—Carmustine—malignant glioma	0.000241	0.00208	CcSEcCtD
Sertraline—Dyspnoea—Temozolomide—malignant glioma	0.00024	0.00207	CcSEcCtD
Sertraline—Somnolence—Temozolomide—malignant glioma	0.00024	0.00207	CcSEcCtD
Sertraline—Pain—Carmustine—malignant glioma	0.000238	0.00206	CcSEcCtD
Sertraline—Constipation—Carmustine—malignant glioma	0.000238	0.00206	CcSEcCtD
Sertraline—Dyspepsia—Temozolomide—malignant glioma	0.000237	0.00205	CcSEcCtD
Sertraline—ABCB1—telencephalon—malignant glioma	0.000234	0.00832	CbGeAlD
Sertraline—Decreased appetite—Temozolomide—malignant glioma	0.000234	0.00202	CcSEcCtD
Sertraline—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000233	0.00201	CcSEcCtD
Sertraline—Fatigue—Temozolomide—malignant glioma	0.000232	0.00201	CcSEcCtD
Sertraline—Pain—Temozolomide—malignant glioma	0.00023	0.00199	CcSEcCtD
Sertraline—Constipation—Temozolomide—malignant glioma	0.00023	0.00199	CcSEcCtD
Sertraline—Feeling abnormal—Carmustine—malignant glioma	0.00023	0.00198	CcSEcCtD
Sertraline—Gastrointestinal pain—Carmustine—malignant glioma	0.000228	0.00197	CcSEcCtD
Sertraline—Feeling abnormal—Temozolomide—malignant glioma	0.000222	0.00192	CcSEcCtD
Sertraline—Abdominal pain—Carmustine—malignant glioma	0.00022	0.0019	CcSEcCtD
Sertraline—Body temperature increased—Carmustine—malignant glioma	0.00022	0.0019	CcSEcCtD
Sertraline—Gastrointestinal pain—Temozolomide—malignant glioma	0.00022	0.0019	CcSEcCtD
Sertraline—Urticaria—Temozolomide—malignant glioma	0.000214	0.00185	CcSEcCtD
Sertraline—Abdominal pain—Temozolomide—malignant glioma	0.000213	0.00184	CcSEcCtD
Sertraline—Body temperature increased—Temozolomide—malignant glioma	0.000213	0.00184	CcSEcCtD
Sertraline—Hypersensitivity—Carmustine—malignant glioma	0.000205	0.00177	CcSEcCtD
Sertraline—Asthenia—Carmustine—malignant glioma	0.0002	0.00173	CcSEcCtD
Sertraline—Hypersensitivity—Temozolomide—malignant glioma	0.000198	0.00171	CcSEcCtD
Sertraline—CYP2B6—brain—malignant glioma	0.000198	0.00702	CbGeAlD
Sertraline—Asthenia—Temozolomide—malignant glioma	0.000193	0.00167	CcSEcCtD
Sertraline—Diarrhoea—Carmustine—malignant glioma	0.000191	0.00165	CcSEcCtD
Sertraline—Pruritus—Temozolomide—malignant glioma	0.000191	0.00165	CcSEcCtD
Sertraline—CYP3A4—central nervous system—malignant glioma	0.000188	0.00668	CbGeAlD
Sertraline—CYP2D6—central nervous system—malignant glioma	0.000185	0.00657	CbGeAlD
Sertraline—Dizziness—Carmustine—malignant glioma	0.000184	0.00159	CcSEcCtD
Sertraline—Diarrhoea—Temozolomide—malignant glioma	0.000184	0.00159	CcSEcCtD
Sertraline—ABCB1—medulla oblongata—malignant glioma	0.000184	0.00653	CbGeAlD
Sertraline—CYP2D6—cerebellum—malignant glioma	0.000181	0.00642	CbGeAlD
Sertraline—Dizziness—Temozolomide—malignant glioma	0.000178	0.00154	CcSEcCtD
Sertraline—Vomiting—Carmustine—malignant glioma	0.000177	0.00153	CcSEcCtD
Sertraline—Rash—Carmustine—malignant glioma	0.000176	0.00152	CcSEcCtD
Sertraline—Dermatitis—Carmustine—malignant glioma	0.000176	0.00152	CcSEcCtD
Sertraline—Headache—Carmustine—malignant glioma	0.000175	0.00151	CcSEcCtD
Sertraline—Vomiting—Temozolomide—malignant glioma	0.000171	0.00148	CcSEcCtD
Sertraline—Rash—Temozolomide—malignant glioma	0.00017	0.00147	CcSEcCtD
Sertraline—Dermatitis—Temozolomide—malignant glioma	0.00017	0.00147	CcSEcCtD
Sertraline—Headache—Temozolomide—malignant glioma	0.000169	0.00146	CcSEcCtD
Sertraline—ABCB1—midbrain—malignant glioma	0.000168	0.00597	CbGeAlD
Sertraline—Nausea—Carmustine—malignant glioma	0.000166	0.00143	CcSEcCtD
Sertraline—ABCB1—spinal cord—malignant glioma	0.000164	0.00583	CbGeAlD
Sertraline—Nausea—Temozolomide—malignant glioma	0.00016	0.00138	CcSEcCtD
Sertraline—CYP2D6—brain—malignant glioma	0.000147	0.00522	CbGeAlD
Sertraline—ABCB1—central nervous system—malignant glioma	0.000133	0.00473	CbGeAlD
Sertraline—ABCB1—cerebellum—malignant glioma	0.00013	0.00462	CbGeAlD
Sertraline—ABCB1—brain—malignant glioma	0.000106	0.00375	CbGeAlD
Sertraline—CYP2C19—Metabolism—COX8A—malignant glioma	2.31e-05	0.000329	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GSTP1—malignant glioma	2.29e-05	0.000326	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—COX8A—malignant glioma	2.26e-05	0.000321	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.24e-05	0.000319	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CAT—malignant glioma	2.23e-05	0.000318	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	2.18e-05	0.00031	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.17e-05	0.000309	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—COX8A—malignant glioma	2.13e-05	0.000303	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—COX8A—malignant glioma	2.11e-05	0.0003	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NCOR1—malignant glioma	2.11e-05	0.0003	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTT1—malignant glioma	2.07e-05	0.000296	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.07e-05	0.000294	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.05e-05	0.000292	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—IDH2—malignant glioma	1.97e-05	0.000281	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ASMT—malignant glioma	1.97e-05	0.00028	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.95e-05	0.000278	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS1—malignant glioma	1.94e-05	0.000277	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.92e-05	0.000274	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.92e-05	0.000273	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ASMT—malignant glioma	1.92e-05	0.000273	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.92e-05	0.000273	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.91e-05	0.000273	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.89e-05	0.00027	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.88e-05	0.000268	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.85e-05	0.000264	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—BCAN—malignant glioma	1.85e-05	0.000263	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ASMT—malignant glioma	1.81e-05	0.000258	CbGpPWpGaD
Sertraline—MAOA—Metabolism—BCHE—malignant glioma	1.81e-05	0.000257	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—BCAN—malignant glioma	1.8e-05	0.000257	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—COX8A—malignant glioma	1.8e-05	0.000257	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ASMT—malignant glioma	1.79e-05	0.000255	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SLC5A5—malignant glioma	1.79e-05	0.000254	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.76e-05	0.000251	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.75e-05	0.00025	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.73e-05	0.000246	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.72e-05	0.000245	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CAV1—malignant glioma	1.72e-05	0.000245	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—BCAN—malignant glioma	1.7e-05	0.000242	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—IDH1—malignant glioma	1.7e-05	0.000241	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—BCAN—malignant glioma	1.68e-05	0.00024	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.68e-05	0.000239	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SPHK1—malignant glioma	1.64e-05	0.000234	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.61e-05	0.00023	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.61e-05	0.000229	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.61e-05	0.000229	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CG—malignant glioma	1.56e-05	0.000223	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ASMT—malignant glioma	1.53e-05	0.000218	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.53e-05	0.000218	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PPARG—malignant glioma	1.51e-05	0.000215	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.5e-05	0.000213	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—IDH2—malignant glioma	1.49e-05	0.000212	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.46e-05	0.000208	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—IDH2—malignant glioma	1.45e-05	0.000207	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BCAN—malignant glioma	1.44e-05	0.000205	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTP1—malignant glioma	1.44e-05	0.000205	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.4e-05	0.0002	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.4e-05	0.0002	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CAT—malignant glioma	1.4e-05	0.000199	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—COX8A—malignant glioma	1.39e-05	0.000198	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CD—malignant glioma	1.37e-05	0.000196	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—IDH2—malignant glioma	1.37e-05	0.000195	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2B6—malignant glioma	1.37e-05	0.000195	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—IDH2—malignant glioma	1.36e-05	0.000193	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.34e-05	0.000191	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NCOR1—malignant glioma	1.32e-05	0.000188	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.31e-05	0.000187	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTT1—malignant glioma	1.3e-05	0.000185	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.29e-05	0.000183	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—IDH1—malignant glioma	1.28e-05	0.000182	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.28e-05	0.000182	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.28e-05	0.000182	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—IDH1—malignant glioma	1.25e-05	0.000178	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.25e-05	0.000178	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.24e-05	0.000177	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SPHK1—malignant glioma	1.24e-05	0.000177	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS1—malignant glioma	1.22e-05	0.000173	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.21e-05	0.000173	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SPHK1—malignant glioma	1.21e-05	0.000172	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CB—malignant glioma	1.2e-05	0.000171	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTGS2—malignant glioma	1.19e-05	0.000169	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2C18—malignant glioma	1.19e-05	0.000169	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ASMT—malignant glioma	1.18e-05	0.000168	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—IDH1—malignant glioma	1.18e-05	0.000168	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—IDH1—malignant glioma	1.17e-05	0.000166	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—IDH2—malignant glioma	1.16e-05	0.000165	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.14e-05	0.000163	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SPHK1—malignant glioma	1.14e-05	0.000162	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.14e-05	0.000162	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—BCHE—malignant glioma	1.13e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SPHK1—malignant glioma	1.13e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.12e-05	0.000159	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.12e-05	0.000159	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BCAN—malignant glioma	1.11e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.11e-05	0.000158	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.1e-05	0.000157	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.09e-05	0.000156	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.09e-05	0.000155	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CAV1—malignant glioma	1.08e-05	0.000153	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.04e-05	0.000149	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.04e-05	0.000149	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTEN—malignant glioma	1.04e-05	0.000148	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.01e-05	0.000143	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—IDH1—malignant glioma	9.98e-06	0.000142	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTT1—malignant glioma	9.82e-06	0.00014	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CG—malignant glioma	9.81e-06	0.00014	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SPHK1—malignant glioma	9.66e-06	0.000138	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTT1—malignant glioma	9.59e-06	0.000137	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.51e-06	0.000135	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPARG—malignant glioma	9.47e-06	0.000135	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.46e-06	0.000135	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.3e-06	0.000133	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS1—malignant glioma	9.2e-06	0.000131	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.18e-06	0.000131	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.17e-06	0.000131	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTT1—malignant glioma	9.03e-06	0.000129	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—malignant glioma	9.01e-06	0.000128	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS1—malignant glioma	8.98e-06	0.000128	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—IDH2—malignant glioma	8.96e-06	0.000128	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTT1—malignant glioma	8.95e-06	0.000128	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.92e-06	0.000127	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CAT—malignant glioma	8.77e-06	0.000125	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CD—malignant glioma	8.63e-06	0.000123	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—BCHE—malignant glioma	8.55e-06	0.000122	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS1—malignant glioma	8.46e-06	0.000121	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SLC5A5—malignant glioma	8.45e-06	0.00012	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.42e-06	0.00012	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS1—malignant glioma	8.39e-06	0.00012	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.36e-06	0.000119	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—BCHE—malignant glioma	8.35e-06	0.000119	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NCOR1—malignant glioma	8.28e-06	0.000118	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SLC5A5—malignant glioma	8.25e-06	0.000117	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.13e-06	0.000116	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.99e-06	0.000114	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.92e-06	0.000113	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—BCHE—malignant glioma	7.87e-06	0.000112	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.84e-06	0.000112	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—BCHE—malignant glioma	7.8e-06	0.000111	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.77e-06	0.000111	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.71e-06	0.00011	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—IDH1—malignant glioma	7.7e-06	0.00011	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTT1—malignant glioma	7.65e-06	0.000109	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.6e-06	0.000108	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CB—malignant glioma	7.52e-06	0.000107	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SPHK1—malignant glioma	7.45e-06	0.000106	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTGS2—malignant glioma	7.45e-06	0.000106	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CA—malignant glioma	7.3e-06	0.000104	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.3e-06	0.000104	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.29e-06	0.000104	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.22e-06	0.000103	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS1—malignant glioma	7.17e-06	0.000102	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.14e-06	0.000102	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.91e-06	9.84e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—malignant glioma	6.81e-06	9.7e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CAV1—malignant glioma	6.75e-06	9.61e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BCHE—malignant glioma	6.67e-06	9.5e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—malignant glioma	6.64e-06	9.46e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CAT—malignant glioma	6.62e-06	9.44e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.58e-06	9.38e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTEN—malignant glioma	6.5e-06	9.26e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CAT—malignant glioma	6.46e-06	9.21e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.3e-06	8.97e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—malignant glioma	6.26e-06	8.92e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NCOR1—malignant glioma	6.26e-06	8.91e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.23e-06	8.87e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—malignant glioma	6.21e-06	8.84e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.17e-06	8.79e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.15e-06	8.76e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NCOR1—malignant glioma	6.11e-06	8.7e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CAT—malignant glioma	6.09e-06	8.68e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CAT—malignant glioma	6.04e-06	8.6e-05	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKT1—malignant glioma	5.97e-06	8.5e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPARG—malignant glioma	5.93e-06	8.45e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTT1—malignant glioma	5.91e-06	8.41e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NCOR1—malignant glioma	5.75e-06	8.2e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NCOR1—malignant glioma	5.7e-06	8.13e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS1—malignant glioma	5.53e-06	7.88e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.4e-06	7.7e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.38e-06	7.67e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—malignant glioma	5.3e-06	7.56e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CAT—malignant glioma	5.16e-06	7.35e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BCHE—malignant glioma	5.14e-06	7.33e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CAV1—malignant glioma	5.1e-06	7.26e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.08e-06	7.24e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CAV1—malignant glioma	4.98e-06	7.09e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NCOR1—malignant glioma	4.87e-06	6.94e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.87e-06	6.94e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.71e-06	6.71e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CAV1—malignant glioma	4.69e-06	6.68e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTGS2—malignant glioma	4.67e-06	6.65e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CAV1—malignant glioma	4.65e-06	6.62e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.64e-06	6.62e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CA—malignant glioma	4.58e-06	6.53e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CG—malignant glioma	4.53e-06	6.46e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPARG—malignant glioma	4.48e-06	6.39e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.44e-06	6.33e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPARG—malignant glioma	4.38e-06	6.23e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.27e-06	6.09e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.24e-06	6.03e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPARG—malignant glioma	4.12e-06	5.87e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—malignant glioma	4.09e-06	5.83e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPARG—malignant glioma	4.09e-06	5.82e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.08e-06	5.82e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTEN—malignant glioma	4.07e-06	5.8e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CD—malignant glioma	3.99e-06	5.68e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CAT—malignant glioma	3.98e-06	5.67e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CAV1—malignant glioma	3.97e-06	5.66e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.8e-06	5.41e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NCOR1—malignant glioma	3.76e-06	5.36e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.76e-06	5.35e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKT1—malignant glioma	3.74e-06	5.33e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.72e-06	5.3e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.62e-06	5.16e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.56e-06	5.07e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTGS2—malignant glioma	3.53e-06	5.02e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPARG—malignant glioma	3.49e-06	4.98e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CB—malignant glioma	3.47e-06	4.95e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTGS2—malignant glioma	3.44e-06	4.9e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.27e-06	4.66e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.25e-06	4.62e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTGS2—malignant glioma	3.24e-06	4.62e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTGS2—malignant glioma	3.22e-06	4.58e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.18e-06	4.53e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTEN—malignant glioma	3.08e-06	4.38e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CAV1—malignant glioma	3.07e-06	4.37e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTEN—malignant glioma	3e-06	4.28e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.87e-06	4.09e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTEN—malignant glioma	2.83e-06	4.03e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTEN—malignant glioma	2.8e-06	3.99e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.79e-06	3.98e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.77e-06	3.95e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTGS2—malignant glioma	2.75e-06	3.91e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPARG—malignant glioma	2.7e-06	3.84e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.46e-06	3.5e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTEN—malignant glioma	2.4e-06	3.41e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKT1—malignant glioma	2.35e-06	3.34e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.17e-06	3.09e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.14e-06	3.05e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTGS2—malignant glioma	2.12e-06	3.02e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CA—malignant glioma	2.12e-06	3.02e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CA—malignant glioma	2e-06	2.84e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.98e-06	2.82e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTEN—malignant glioma	1.85e-06	2.63e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKT1—malignant glioma	1.77e-06	2.52e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKT1—malignant glioma	1.73e-06	2.46e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.69e-06	2.41e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKT1—malignant glioma	1.63e-06	2.32e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKT1—malignant glioma	1.62e-06	2.3e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKT1—malignant glioma	1.38e-06	1.97e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.3e-06	1.86e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKT1—malignant glioma	1.07e-06	1.52e-05	CbGpPWpGaD
